Kirkland & Ellis is representing WeBull Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati is representing SK Growth Opportunities Corporation. Webull Corporation (“Webull” or the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ji Xing Pharmaceuticals Limited (JIXING) on the transaction. TMS Co., Ltd. (TMS) and Ji Xing Pharmaceuticals Limited (JIXING) announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ambient Fuels on the transaction. On May 17, 2023, Generate Capital, a leading sustainable infrastructure investment and operating company, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Caption Health on the acquisition. GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised project44 on the deal. project44, the leading supply chain visibility platform, announced that it raised an $80 million funding round led by sustainable...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised AliveCor on the deal. AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced its Series F Financing led by GE Healthcare....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised InSilico Medicine on the deal. Ashurst represented Mirae Asset Capital. Hong Kong-based InSilico Medicine, a global leader in end-to-end artificial...
You must be a Standard 1 Year member to access this content.
